Senior Management changes at BMS

 

Bristol-Myers Squibb (BMS) has made alterations to its Senior Management Team.

Giovanni Caforio has been promoted to President of US Pharmaceuticals from senior vice president of Oncology and Immunology Global Commercialisation, replacing Anthony Hooper, who has decided to leave the company.

In addition, Charles Bancroft and Béatrice Cazala have both been appointed as Executive Vice Presidents of the company, reporting to Lamberto Andreotti, CEO of BMS.

Mr Andreotti said that he looked forward “to working with these three senior leaders and the rest of my management team to continue to successfully execute our BioPharma strategy”.

Bristol-Myers Squibb is a global biopharmaceutical company aiming to discover, develop and deliver medicines to patients with serious diseases.